Toxoplasma gondii chronic infection decreases visceral nociception through peripheral opioid receptor signaling
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013106 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Alexis Audibert und 12 weiteren Autor:innen. Beteiligte Einrichtung: Toulouse Institute for Infectious and Inflammatory Diseases, Infinity, Inserm, CNRS, University of Toulouse, Toulouse, France. Hauptthemen laut MEDLINE: Toxoplasma, Toxoplasmosis, Nociception, Receptors, Opioid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inserm, “Agence Nationale pour la Recherche”, “Fondation pour la Recherche sur le Cerveau”.
Abstract (Originalsprache)
By eliciting immune activation in the digestive tract, intestinal pathogens may perturb gut homeostasis. Some gastrointestinal infections can indeed increase the risk of developing post-infectious irritable bowel syndrome (PI-IBS). Intriguingly, the prevalent foodborne parasite Toxoplasma gondii has not been linked to the development of PI-IBS and the impact of this infection on colon homeostasis remains ill-defined. We show in a mouse model that latent T. gondii decreases visceral nociceptive responses in an opioid signaling-dependent manner. Despite the accumulation of Th1 and cytotoxic T cells in the colon of latently infected mice, the selective invalidation of enkephalin gene in T cells ruled out the involvement of T cell-derived enkephalins in hypoalgesia. These findings provide clues about how this widespread infection durably shapes the gut immune landscape and modifies intestinal physiological parameters. They suggest that in contrast to other gut microbes, T. gondii infection could be negatively associated with abdominal pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Toulouse Institute for Infectious and Inflammatory Diseases, Infinity, Inserm, CNRS, University of Toulouse, Toulouse, France.
- IRSD, Inserm, INRAE, ENVT, University of Toulouse, Toulouse, France.
- Centre d'Immunologie et des Maladies Infectieuses (CIMI-PARIS), Inserm, CNRS, Sorbonne University, Paris, France.
ORCID-Profile: Nicolas Blanchard
Förderung
- Inserm
- “Agence Nationale pour la Recherche”
- “Fondation pour la Recherche sur le Cerveau”
- French Minister of Research
- “Fondation pour la Recherche Médicale” (FRM)
- Agence Nationale de la Recherche
- Fondation pour la recherche sur le cerveau
- Fondation pour la Recherche Médicale
Zitieren
APA
Audibert, A., Mas-Orea, X., Rey, L., Belloy, M., Bassot, E., Battut, L., Marodon, G., Masson, F., Serino, M., Cenac, N., Dietrich, G., Bonnart, C., & Blanchard, N. (2025). Toxoplasma gondii chronic infection decreases visceral nociception through peripheral opioid receptor signaling. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013106
Vancouver
Audibert A, Mas-Orea X, Rey L, Belloy M, Bassot E, Battut L, et al. Toxoplasma gondii chronic infection decreases visceral nociception through peripheral opioid receptor signaling. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013106
BibTeX
@article{Audibert2025,
author = {Audibert, Alexis and Mas-Orea, Xavier and Rey, Léa and Belloy, Marcy and Bassot, Emilie and Battut, Louise and Marodon, Gilles and Masson, Frederick and Serino, Matteo and Cenac, Nicolas and Dietrich, Gilles and Bonnart, Chrystelle and Blanchard, Nicolas},
title = {Toxoplasma gondii chronic infection decreases visceral nociception through peripheral opioid receptor signaling},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013106}
}
EUVIMED